Table 1 Evidence of immunological causes in patient cohorts with assumed primary forms of obsessive-compulsive disorders (extracted from [26]).
Pro-inflammatory cytokines | |
---|---|
Gray and Bloch, 2012 (Meta-analysis) [55] | • Decreased IL-1β levels and decreased TNFα levels in non-depressed patients with OCD |
• Increased IL-6 levels in adult (medication-free) patients with OCD | |
Jiang et al., 2018 (Meta-analysis) [56] | • TNF-α-238G/A gene polymorphism could lead to a decreased risk of OCD susceptibility |
Cosco et al., 2019 (Systematic review and meta-analysis) [54] | • No alterations in different immune mediators (IL-1β, IL-4, IL-6, IL-10, TNF-α, and interferon-γ). |
Antibodies/Infections | |
Pearlman et al., 2014 (Meta-analysis) [57] | • High frequency of anti-basal ganglia antibodies |
Sutterland et al., 2015 (Meta-analysis) [58] | • Association with toxoplasma infection |
Lamothe et al., 2018 (Systematic review) [26] | • High frequency anti-streptolysin O, anti-streptokinase, and anti-DNase B antibodies (e.g., [59]) |
• Anti-dopamine (D1/2) receptor antibodies and anti-lysoganglioside antibodies are more frequent in patients with PANDAS and obsessive-compulsive symptoms (e.g., [60]) | |
• Anti-enolase antibodies are frequent [61] | |
• More CSF anti-brain antibody binding to basal ganglia and thalamus was described [62] | |
• Herpes IgG antibodies were more frequent in CSF of patients compared with controls [63] |